Feature

Article

Pharmaceutical Executive

Pharmaceutical Executive: March 2024
Volume44
Issue 3

Pharmaceutical Executive: March 2024 Issue (PDF)

Click the title above for a link to open the Pharmaceutical Executive March 2024 issue in an interactive PDF format.

March 2024
Download Issue PDF
Articles in this issue
Pharmaceutical Executive: March 2024 Issue (PDF)
Pharmaceutical Executive: March 2024 Issue (PDF)
How’s Business?
How’s Business?
Eyeing Efficiency for All
Eyeing Efficiency for All
Industry Business Check: Market Review Rates the Latest Full-Year Outputs
Industry Business Check: Market Review Rates the Latest Full-Year Outputs
Positioning Medical Information as a Trust Driver for Your Brand
Positioning Medical Information as a Trust Driver for Your Brand
Straight and Simple Advice Lives On in the Pharma Industry
Straight and Simple Advice Lives On in the Pharma Industry

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Pharmaceutical Executive
Peter Rubin
Related Content
Stock.adobe.com
September 30th 2025

FDA Grants Approval for Kedrion Biopharma’s Primary Humoral Immunodeficiency Treatment Qivigy

Nicholas Jacobus
Pharmaceutical Executive
September 30th 2025

Pharmaceutical Executive Daily: September 29, 2025

Nicholas Jacobus
Stock.adobe.com
September 30th 2025

Novo Nordisk Resubmits Biologics License Application to FDA for Awiqli

Nicholas Jacobus
Pharmaceutical Executive
September 30th 2025

Pharmaceutical Executive Daily: September 26, 2025

Nicholas Jacobus
Stock.adobe.com
September 30th 2025

AbbVie Breaks Ground on Illinois API Manufacturing Site

Mike Hollan
Stock.adobe.com
September 30th 2025

Genmab Acquires Merus in $8 Billion Transaction Agreement Including Late-Stage Breakthrough Therapy Asset Petosemtamab

Nicholas Jacobus
© 2025 MJH Life Sciences

All rights reserved.